Cargando…
Bovine antibodies targeting primary and recurrent Clostridium difficile disease are a potent antibiotic alternative
The increased incidence of antibiotic resistant ‘superbugs’ has amplified the use of broad spectrum antibiotics worldwide. An unintended consequence of antimicrobial treatment is disruption of the gastrointestinal microbiota, resulting in susceptibility to opportunistic pathogens, such as Clostridiu...
Autores principales: | Hutton, Melanie L., Cunningham, Bliss A., Mackin, Kate E., Lyon, Shelley A., James, Meagan L., Rood, Julian I., Lyras, Dena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473923/ https://www.ncbi.nlm.nih.gov/pubmed/28623367 http://dx.doi.org/10.1038/s41598-017-03982-5 |
Ejemplares similares
-
CdtR Regulates TcdA and TcdB Production in Clostridium difficile
por: Lyon, Shelley A., et al.
Publicado: (2016) -
Spo0A Differentially Regulates Toxin Production in Evolutionarily Diverse Strains of Clostridium difficile
por: Mackin, Kate E., et al.
Publicado: (2013) -
Disruption of the Gut Microbiome: Clostridium difficile Infection and the Threat of Antibiotic Resistance
por: Johanesen, Priscilla A., et al.
Publicado: (2015) -
Novel Molecular Type of Clostridium difficile in Neonatal Pigs, Western Australia
por: Squire, Michele M., et al.
Publicado: (2013) -
Toxin B is essential for virulence of Clostridium difficile
por: Lyras, Dena, et al.
Publicado: (2009)